Cell Line with Stable Expression of Human Cardiac Sodium Channel (hH1, a.k.a. hNav1.5, SCN5A)

The invention is a cell line (Human embryonic kidney 293) stably expressing a recombinant human cardiac voltage-gated sodium channel (hHl). The cells enable high throughput screening of compounds that modulate sodium channel activity.
Inventors: 
Alfred GeorgeDao Wang
Licensing manager: 
Karen Rufus

Featured Video

Vanderbilt Patent Activity

View Vanderbilt University Patents

CTTC on Twitter